Amrutam Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 1 Year 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.11 M
About Amrutam Pharmaceuticals
Amrutam Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2023 (One year and ten months 25 days old ). Its registered office is in Gwalior, Madhya Pradesh, India.
The Company is engaged in the Paper Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹3.11 M.
Stuti Gupta, Agnim Gupta, and Chandra Gupta serve as directors at the Company.
Company Details
-
Location
Gwalior, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U21003MP2023PTC064911
-
Company No.
064911
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Mar 2023
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Amrutam Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Agnim Gupta
|
Director | 21-Mar-2023 | Current |
|
Stuti Gupta
|
Director | 12-Apr-2023 | Current |
|
Chandra Gupta
|
Director | 21-Mar-2023 | Current |
Financial Performance of Amrutam Pharmaceuticals.
Enhance accessibility to Amrutam Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amrutam Pharmaceuticals?
Unlock access to Amrutam Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Onashi Nature Private LimitedStuti Gupta and Agnim Gupta are mutual person
-
Mercury M. Agency Private LimitedAgnim Gupta and Chandra Gupta are mutual person
-
Evenleap Studios Llp
Agnim Gupta is a mutual person
Charges (Loans)
₹3.11 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2023 | Hdfc Bank Limited | ₹1.10 M | Open |
| 06 Dec 2023 | Hdfc Bank Limited | ₹2.01 M | Open |
How Many Employees Work at Amrutam Pharmaceuticals?
Unlock and access historical data on people associated with Amrutam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amrutam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amrutam Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.